Introduction {#s001}
============

M[ore than one-third]{.smallcaps} of women with breast cancer experience significant emotional distress, anxiety, and/or depression following diagnosis.^[@B1]^ Anticipating surgery for breast cancer can create negative cognitions and emotions, such as anxiety and fear.^[@B2]^ Higher preoperative distress is associated with poorer psychological outcomes following breast cancer surgery.^[@B3]^ Psychological distress may adversely impact pain perception, immune-mediated wound healing, and return to physical function.^[@B4]^ Consequently, it is important to investigate nonpharmacologic interventions that might help decrease preoperative emotional distress.

Psychological preparation before surgery {#s002}
----------------------------------------

Preoperative psychological preparation lessens postoperative pain and negative affect across a range of clinical populations.^[@B5]^ A recent meta-analysis found strategies, including relaxation, hypnosis, procedural information, or describing sensations one might experience had statistically significant impact on negative affect, whereas relaxation and techniques to help contextualize emotions were more effective in alleviating postoperative pain.^[@B4]^

Mind and body techniques in cancer populations {#s003}
----------------------------------------------

Among the most commonly studied mind and body techniques are breathing exercises, mindfulness meditation, progressive muscle relaxation (PMR), guided imagery, and self-hypnosis. These physical and cognitive relaxation strategies induce muscle relaxation and instill mental and emotional calm.^[@B6]^ They are simple to learn, can be practiced virtually anywhere, are considered safe, and can be effectively used as self-management strategies.^[@B7]^

Strategies using a combination of mind and body techniques have safely and effectively decreased psychological distress in cancer populations.^[@B8]^ The combination of breathing exercises and PMR has been shown to decrease anxiety and emotional distress in diverse cancer populations.^[@B9]^ Guided imagery combined with breathing and PMR has improved anxiety and distress in persons with cancer as well.^[@B12],[@B13]^ Practice of the standardized mindfulness-based stress reduction program has improved anxiety and mood symptoms in cancer populations,^[@B14],[@B15]^ as have shorter versions of mindfulness meditation training.^[@B16]^ Brief hypnosis interventions have significantly reduced emotional distress related to invasive medical procedures^[@B19]^; pain, anxiety, and procedure length^[@B20]^; emotional upset and depressed mood; and increased relaxation compared with attention-control groups.^[@B21]^ In light of this evidence, the authors created a self-care toolkit (SCT) with mind--body audio-files to be used pre- and postoperatively to address perisurgical distress and pain.

The present study aimed primarily to determine whether an SCT with guided mind--body techniques (breathing, PMR, meditation, guided imagery, self-hypnosis suggestions) delivered pre- and postoperatively would be more effective in decreasing anxiety in women newly diagnosed with breast cancer than treatment as usual (TAU). The study also tested the effects of the SCT on secondary outcomes of pain, nausea, sleep, fatigue, global health, quality of life (QOL), and inflammatory blood markers. The authors hypothesized that when compared with a TAU control group, the SCT group would have improved (1) anxiety, pain intensity, pain interference, sleep, fatigue, global health status, QOL scores, and inflammatory blood markers (erythrocyte sedimentation rate \[ESR\] and C-reactive protein \[CRP\]) at longer term time points (T1 vs. T4); and (2) anxiety, pain, and nausea in the immediate pre- to postoperative time periods (T2 vs. T3).

Materials and Methods {#s004}
=====================

SCT development and testing {#s005}
---------------------------

The SCT contains an MP3 player with audio-files of mind--body skills (i.e., breathing, relaxation, meditation, guided imagery, and self-hypnosis suggestions) and tools (i.e., Sea-Band^®^ acupressure wristbands and journal). It was designed to help individuals regulate their physiologic and emotional reactions to stressful situations, prevent symptoms associated with surgery and anesthesia (i.e., pain, anxiety, nausea, insomnia, and fatigue), and enhance postoperative recovery. The SCT components are described in [Table 1](#T1){ref-type="table"}.

###### 

[Self-Care Toolkit Components]{.smallcaps}

  *Component*                                                   *Description*
  ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Manual                                                        Spiral-bound instruction manual with a section to be used as a journal
  Sea-Band^®^ acupressure wristband                             FDA-approved medical device designed to apply pressure to the P6 or "Nei-Kuan," acupuncture point to decrease nausea
  MP3 player with headphones                                    Includes seven audio-files designed to teach individuals self-regulating skills to enhance relaxation and diminish anxiety, pain, fatigue, nausea, and insomnia
  Track 1: Introduction (1:17 min)                              Instructions about how to use the toolkit, disclaimer about use only when in safe relaxing environment
  Track 2: Breathing exercise with introduction (4:56 min)      Diaphragmatic breathing exercise with instructions how to position the body, notice chest versus diaphragmatic breathing
  Track 3: Breathing exercise without introduction (3:31 min)   Diaphragmatic breathing exercise without introduction
  Track 4: Mindfulness meditation exercise (11:29 min)          Guided meditation to pay attention to the in-breath, the out-breath, sounds, chosen mantra
  Track 5: PMR (17:53 min)                                      Guided exercise to sequentially tense and relax muscle groups from head, upper body, and midbody to lower body and extremities
  Track 6: Guided imagery and preprocedure track (21:19 min)    Breathing and relaxation induction with safe place imagery; specific suggestions for deepening relaxation with environmental cues, confidence in healthcare team, restoring comfort, normal body function, healing, restful sleep, energy, and strength postoperatively
  Track 7: Guided imagery and postprocedure track (19:32 min)   Imagery with healing island of serenity; specific suggestions for trusting body\'s inner wisdom, advancing diet while making healthy choices, being patient with the healing process, restful sleep, energy, and strength

PMR, progressive muscle relaxation.

The content for the audio-files was created specifically for this toolkit by mind--body experts. The breathing, PMR, and meditation tracks were created by a mind--body subject matter expert (Katherine Smith) with extensive training and experience teaching experiential mind--body workshops and courses. The guided imagery and two procedural tracks were created by one of the investigators (D.B.), who is a nurse practitioner and mind--body researcher with certifications in hypnotherapy and Interactive Guided Imagery^SM^. The scripts for the audio-files were vetted externally with subject matter experts in mind--body medicine and revised based on their feedback. The audio-files were recorded at a professional recording studio. Background instrumental music was included only on the two guided imagery procedural tracks. Both researchers created the content for the SCT instructional manual.

The research team conducted an initial institutional review board (IRB)-approved product evaluation study in a cohort of twelve adults undergoing elective cosmetic surgery. Participants responded favorably, stating that the mind--body skills were easy to learn and helpful before surgery. Negative comments focused on physical attributes of the toolkit (e.g., difficulty navigating tracks on the MP3 player, uncomfortable earbuds, and bulky manual). The research team incorporated the suggested improvements and used the modified SCT in the present study.

Study design overview {#s006}
---------------------

This two-group, nonblinded, randomized controlled study was conducted in 100 women recently diagnosed with nonmetastatic breast cancer, for whom surgery was the initial treatment. Participants were randomized to either receive the SCT in addition to usual medical care or TAU only. Data were collected at baseline (T1), immediately before surgery (T2), within 10 h postoperatively (T3), and ∼2 weeks postsurgery (T4).

Setting {#s007}
-------

The study was approved to be conducted at two sites: Brooke Army Medical Center (BAMC) and Carl R. Darnall Army Medical Center (CRDAMC). Regulatory approvals were obtained from the Department of Clinical Investigation (DCI) and BAMC IRB, and by the Human Research Protection Office at U.S. Army Medical Research and Materiel Command. The protocol was registered on [clinicaltrials.gov](clinicaltrials.gov) (ID: NCT02387320). All study staff completed relevant Collaborative Institutional Training Initiative (CITI) training before study initiation.

Participants {#s008}
------------

Eligible participants included women older than 18 years who were newly diagnosed with nonmetastatic breast cancer and for whom surgery (e.g., lumpectomy or mastectomy) would be their initial treatment. Exclusion criteria included women who received neoadjuvant treatment or individuals with severe hearing impairment who would be unable to listen to the audio-files.

Study procedures {#s009}
----------------

Research staff recruited potential study participants from the BAMC and CRDAMC General Surgery Departments. During their multidisciplinary oncology appointment, women diagnosed with breast cancer received an IRB-approved study flyer and were invited to meet with a researcher to learn about the study. Women meeting eligibility criteria and voicing interest in participation attended a baseline appointment, during which they received a detailed explanation of the study and signed IRB-approved informed consent documents. Participants were randomized to either the SCT or TAU group using a random integer generator.^[@B22]^ Due to the nature of the intervention, blinding was not possible.

Interventions {#s010}
-------------

SCT group participants received instruction about the toolkit\'s components and demonstration of the MP3 player and acupressure wristbands by the research assistant. Participants were asked to read the manual and listen to each of the seven audio-files at least once, but encouraged to use them as many times as desired during the 2-week preoperative and postoperative periods. In addition, they were asked to wear the acupressure wristbands during surgery and instructed to remove them if they experienced adverse reactions.

Women randomized to the TAU group received perioperative medical care as per their oncology team. They received the SCT on study completion since the mind--body skills and antinausea wristbands could be used during future cancer treatments.

Outcome measures {#s011}
----------------

Self-reported survey data were collected using Wi-Fi-enabled tablets at four time points. Primary and secondary outcome measures are shown in [Table 2](#T2){ref-type="table"}. The primary outcome, anxiety, was measured by the NIH Patient-Reported Outcomes Measurement Information System (PROMIS-57) Anxiety subscale. Secondary outcomes for Pain Intensity, Pain Interference, Fatigue, and Sleep Disturbance were measured with the corresponding NIH PROMIS-57 subscales. PROMIS-57 also includes subscales for Depression, Physical Function, and Satisfaction with Social Roles, which were not expected to be affected, but were administered as part of the full measure. The PROMIS-57 scales have excellent internal consistency to show expected patterns of convergent and discriminant validity.^[@B23]^ Two questions from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), which have been tested extensively in cancer populations,^[@B24]^ independently measure self-assessment of global health and overall QOL over the prior week on a 7-point Likert scale from 1 (very poor) to 7 (excellent). ESR and CRP levels were obtained to determine if the SCT group had comparatively lower inflammatory biomarker levels. Due to diurnal variability of ESR and CRP, laboratory draws were generally done before 10:00 [am]{.smallcaps} at T1, T2, and T4.^[@B25]^

###### 

[Primary and Secondary Outcome Measures]{.smallcaps}

  *Instrument*                                                             *Constructs*                                                                                                                                                                                                                                                                                                                                                                                            *Baseline (T1)*   *Preoperative (T2)*   *Postoperative (T3)*   *Two-week follow-up (T4)*
  ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- --------------------- ---------------------- ---------------------------
  Demographics Survey                                                      Demographics, breast cancer stage, type of surgery, past use of integrative techniques                                                                                                                                                                                                                                                                                                                  X                                                               
  NIH PROMIS-57                                                            Anxiety,^[a](#tf2){ref-type="table-fn"}^ Pain Intensity,^[b](#tf3){ref-type="table-fn"}^ Pain Interference,^[b](#tf3){ref-type="table-fn"}^ Fatigue,^[b](#tf3){ref-type="table-fn"}^ Sleep Disturbance,^[b](#tf3){ref-type="table-fn"}^ Satisfaction with Social Roles,^[c](#tf4){ref-type="table-fn"}^ Physical Function,^[c](#tf4){ref-type="table-fn"}^ Depression^[c](#tf4){ref-type="table-fn"}^   X                 X                                            X
  EORTC QLQ-C30^[b](#tf3){ref-type="table-fn"}^ (two items)                Global health status, Quality of life                                                                                                                                                                                                                                                                                                                                                                   X                                                              X
  GA-VAS^[a](#tf2){ref-type="table-fn"}^                                   Anxiety                                                                                                                                                                                                                                                                                                                                                                                                                   X                     X                       
  Defense and Veterans Pain Rating Scale^[b](#tf3){ref-type="table-fn"}^   Pain                                                                                                                                                                                                                                                                                                                                                                                                                      X                     X                       
  Nausea VAS^[b](#tf3){ref-type="table-fn"}^                               Nausea                                                                                                                                                                                                                                                                                                                                                                                                                    X                     X                       
  Inflammatory biomarkers^[b](#tf3){ref-type="table-fn"}^                  ESR, CRP                                                                                                                                                                                                                                                                                                                                                                                                X                 X                                            X
  Satisfaction survey^[d](#tf5){ref-type="table-fn"}^                      Satisfaction, use, helpfulness of SCT                                                                                                                                                                                                                                                                                                                                                                                                                                  X
  Qualitative Interview^[d](#tf5){ref-type="table-fn"}^                    Open-ended questions about SCT                                                                                                                                                                                                                                                                                                                                                                                                                                         X

Primary outcomes.

Secondary outcomes.

Other NIH PROMIS-57 subscales.

Administered only to SCT group.

CRP, C-reactive protein; EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Questionnaire Core 30; ESR, erythrocyte sedimentation rate; GA-VAS, General Anxiety-Visual Analog Scale; PROMIS, Patient-Reported Outcomes Measurement Information System; SCT, self-care toolkit; VAS, Visual Analog Scale.

Three single-item measures were administered pre- and postoperatively to determine whether the SCT had immediate effects on anxiety, pain, and nausea. The 10-cm General Anxiety-Visual Analog Scale (GA-VAS) correlates well with other anxiety measures, with minimally important difference (MID) estimates clustering between 10 and 15 mm.^[@B26]^ The Defense and Veterans Pain Rating Scale (DVPRS) is a self-reported graphic pain scale from 0 to 10 (0 = "no pain" to 10 = "as bad as it could be, nothing else matters") with an internal consistency reliability of Cronbach\'s alpha of 0.902.^[@B27]^ A standard 10-cm Visual Analog Scale (VAS; 0--10 cm) measured nausea on a scale from 0 to 10 (0 = "no nausea" to 10 = "extreme nausea").

Two assessments administered to the SCT group at follow-up (T4) were a satisfaction survey and a brief qualitative interview with open-ended questions.

Statistical methods {#s012}
-------------------

The sample size calculation was based on expected minimal detectable effect size for the primary outcome of change in anxiety over time using the PROMIS-57 anxiety subscale. Using a 0.05 significance level and 80% power, the required sample size was estimated at 45 participants per group to detect a 0.6 mean difference in effect size (Cohen\'s *d*). Assuming a 10% participant dropout or lost to follow-up rate, an enrollment of 50 participants per group was required.

Subjects were compared using an intent-to-treat model based on their randomization assignment. Categorical variables and frequency counts were analyzed using chi-square or Fisher\'s exact tests, whichever was most appropriate. Means and standard deviations (SDs) were used as summary statistics for continuous variables and analyzed using Student\'s *t* test, analysis of variance (ANOVA), and/or Wilcoxon\'s test. For data measured at two time points, the delta change in values was calculated to detect within-group differences in SCT and TAU using Wilcoxon\'s rank sum test or paired *t* test. For factors measured at more than two time points, a two-way repeated measures ANOVA (RM-ANOVA) was implemented with a Bonferroni corrected *post hoc* analysis to determine between-group differences at each time point. Significance for results was established when *p*-values were \<0.05. All statistical analyses were performed using SPSS v22.0 (IBM Corp.).

Results {#s013}
=======

Participant flow {#s014}
----------------

A total of 316 potential participants were screened for eligibility at BAMC and CRDAMC from April 2014 to June 2017. Of these, 216 were excluded for not meeting eligibility criteria (21%) or choosing not to participate (79%). Most declining participation cited lack of available personal time. One hundred participants were enrolled and randomly assigned to either one of two groups: SCT (*n* = 51) or TAU (*n* = 49) group. Four participants voluntarily withdrew from the study: two received treatment at another facility, one required neoadjuvant chemotherapy, and the fourth moved out of the area ([Fig. 1](#f1){ref-type="fig"}). Fourteen participants were lost to follow-up and did not complete the 2-week follow-up measures. None of the study participants experienced any adverse effects.

![Participant CONSORT diagram. CONSORT, Consolidated Standards of Reporting Trials. SCT, self-care toolkit.](fig-1){#f1}

Participant demographics {#s015}
------------------------

The majority of the women enrolled were Caucasian (59%), military dependents (68%), older than 45 years (87%), and with a Bachelor\'s degree (57%). Nearly half (42%) were diagnosed with Stage I breast cancer and the proportions of anticipated mastectomy and lumpectomy surgeries were not significantly different between study groups (*p* = 0.341). Thirty-four percent of participants were familiar with integrative modalities and 13% stated they had used them previously. No significant differences were detected between study groups at baseline for any demographic variables ([Table 3](#T3){ref-type="table"}).

###### 

[Participant Demographics]{.smallcaps}

                                         *SCT* n *(%)*   *TAU* n *(%)*   p
  -------------------------------------- --------------- --------------- -------
  Age (years)                                                            
   31--35                                1 (2)           0 (0)           0.476
   36--45                                5 (11)          6 (13)          
   \>45                                  42 (87)         39 (87)         
  Race                                                                   
   Caucasian/white                       31 (66)         23 (51)         0.148
   African American                      7 (12)          13 (27)         
   Hispanic/Latino                       9 (19)          5 (11)          
   Asian/Pacific Islander                1 (2)           3 (7)           
  Highest education level                                                
   No high school diploma                0 (0)           0 (0)           0.113
   High school diploma                   6 (12)          4 (9)           
   Vocational school                     1 (2)           2 (4)           
   Some college                          9 (19)          9 (20)          
   Associates                            9 (19)          4 (9)           
   Bachelors                             12 (26)         14 (31)         
   Masters                               10 (21)         7 (16)          
   PhD                                   0 (0)           5 (11)          
  Military status                                                        
   Active duty                           5 (11)          2 (4)           0.58
   Reservist                             1 (2)           0 (0)           
   National Guard                        0 (0)           0 (0)           
   Retired                               10 (21)         9 (20)          
   Dependent                             30 (64)         33 (73)         
   Civil service                         1 (2)           1 (2)           
  Pay grade                                                              
   E1--E4                                1 (2)           0 (0)           0.106
   E5--E6                                1 (2)           0 (0)           
   E7--E9                                1 (2)           2 (4)           
   W1--W5                                2 (4)           0 (0)           
   01--03                                0 (0)           0 (0)           
   04--06                                5 (11)          1 (2)           
   Other                                 37 (79)         42 (93)         
  Marital status                                                         
   Married, together                     34 (72)         36 (80)         0.097
   Married, separate                     1 (2)           2 (4)           
   Separated                             0 (0)           1 (2)           
   Divorced                              1 (2)           3 (7)           
   Widowed                               0 (0)           3 (7)           
   In relationship                       2 (4)           0 (0)           
   Single                                3 (6)           0 (0)           
  Years with spouse                      6.0 ± 1.7       6.2 ± 1.7       0.574
  Cancer stage                                                           
   Stage 0                               19 (40)         15 (33)         0.56
   Stage I                               20 (42)         19 (4)          
   Stage II                              8 (17)          10 (22)         
   Stage III                             0 (0)           1 (2)           
  Surgery type                                                           
   Lumpectomy                            24 (52)         19 (48)         0.341
   Mastectomy                            19 (42)         26 (58)         
  Breast                                                                 
   Right breast                          20 (42)         22 (49)         0.353
   Left breast                           22 (47)         15 (33)         
   Both                                  5 (11)          8 (18)          
  Familiar with integrative modalities                                   
   Yes                                   19 (40)         12 (27)         0.161
   No                                    28 (60)         33 (73)         
  Past use of integrative modalities                                     
   Yes                                   6 (12)          6 (13)          0.936
   No                                    41 (87)         39 (87)         

SCT, self-care toolkit; TAU, treatment as usual.

SCT use and satisfaction {#s016}
------------------------

Most participants in the SCT group completed the satisfaction survey (*n* = 36; 71%) and provided feedback about the toolkit. All respondents endorsed using the SCT and the MP3 player; however, there were variations in use of the individual components ([Table 4](#T4){ref-type="table"}).

###### 

[Reported Use of Self-Care Toolkit Components]{.smallcaps}

                                                                        *Frequency of use*   
  --------------------------------------------------------- ----- ----- -------------------- -----
  Overall toolkit                                           100   97    ---                  ---
  Manual                                                    74    93    85                   15
  Journal                                                   40    71    61                   39
  Wristbands                                                66    67    64                   37
  MP3 player                                                100   97    33                   67
   Track 1: Introduction                                    80    89    96                   4
   Track 2: Breathing with instructions                     89    100   73                   27
   Track 3: Breathing without instructions                  91    97    41                   59
   Track 4: Meditation                                      94    80    47                   53
   Track 5: PMR                                             91    87    48                   52
   Track 6: Guided imagery with preoperative suggestions    86    83    73                   27
   Track 7: Guided imagery with postoperative suggestions   83    93    76                   24

Participants who used component only once or several times over the study.

Participants who used component many times, daily, or \>1 time a day.

SCT, self-care toolkit; PMR, progressive muscle relaxation.

The most commonly used mind--body audio-files were the meditation (94%), PMR (91%), and breathing (91%) tracks. Participants also reported listening to the guided imagery with preoperative (86%) and postoperative (83%) suggestions. The least used component was the journal section of the manual (40%). About two-thirds reported using the antinausea wristbands and a similar proportion found them helpful. The components rated most helpful were the breathing track with instructions (100%), guided imagery with postoperative suggestions (93%), and PMR (87%) tracks. Overall, 94% of SCT participants were very satisfied or satisfied with the toolkit and 74% rated the quality as very good or good ([Table 4](#T4){ref-type="table"}). Analyses to examine correlations between frequency of SCT use and outcomes showed no significant relationships; however, the small subgroup sample sizes were underpowered to show effects (data not shown).

Symptom changes over time {#s017}
-------------------------

### Baseline (T1) to preoperative (T2) time interactions {#s018}

Baseline values were higher in the SCT group when compared with the TAU group for PROMIS-57 subscales of Anxiety (*p* = 0.0045), Pain Intensity, Pain Interference, Fatigue (*p* = 0.0147), and Sleep Disturbance. The mean change in the primary outcome, PROMIS Anxiety, from T1 to T2 in the SCT group was −5.08 (SD 5.61) and in the TAU group −1.70 (SD 10.96); however, this was not statistically significant (*p* = 0.098). For all other PROMIS-57 subscales, there were no significant between-group mean differences from T1 to T2 ([Table 5](#T5){ref-type="table"}).

###### 

[Between-Group Differences in Patient-Reported Outcomes Measurement Information System-57 Subscales]{.smallcaps}

                                                  *Baseline (T1)*   *Preoperative (T2)*   *Follow-up (T4)*   *Preoperative to baseline (T2 vs. T1)*   *Follow-up to baseline (T4 vs. T1)*                   
  ----------------------------------------------- ----------------- --------------------- ------------------ ---------------------------------------- ------------------------------------- --------------- -----------------------------------------
  Anxiety                                                                                                                                                                                                   
   SCT                                            59.91 (7.91)      54.67 (7.92)          51.43 (9.54)       −5.08 (5.61)                             0.098                                 −8.96 (8.45)    0.099
   TAU                                            55.22 (9.38)      53.97 (9.34)          48.67 (8.40)       −1.7 (10.96)                                                                   −5.69 (8.63)     
  Pain Intensity                                                                                                                                                                                            
   SCT                                            2.34 (2.29)       2.26 (2.54)           3.02 (2.19)        −0.17 (2.05)                             0.267                                 0.32 (1.72)     0.095
   TAU                                            1.82 (2.42)       1.35 (2.23)           2.78 (2.16)        −0.72 (2.13)                                                                   1.08 (2.14)      
  Pain Interference                                                                                                                                                                                         
   SCT                                            50.25 (9.11)      48.59 (9.64)          54.67 (8.15)       −2.68 (7.23)                             0.522                                 2.89 (8.92)     0.005^[\*](#tf12){ref-type="table-fn"}^
   TAU                                            46.49 (8.97)      45.70 (8.79)          56.20 (10.45)      −1.58 (7.53)                                                                   9.93 (11.92)     
  Fatigue                                                                                                                                                                                                   
   SCT                                            51.25 (10.02)     49.66 (9.56)          51.76 (8.15)       −1.03 (7.01)                             0.938                                 0.02 (7.64)     0.023^[\*](#tf12){ref-type="table-fn"}^
   TAU                                            46.30 (10.91)     44.84 (10.33)         50.70 (9.74)       −1.16 (7.84)                                                                   4.13 (7.82)      
  Sleep Disturbance                                                                                                                                                                                         
   SCT                                            52.65 (3.69)      52.94 (3.97)          52.70 (3.51)       0.36 (3.66)                              0.625                                 −0.29 (4.10)    0.351
   TAU                                            51.54 (3.96)      52.44 (4.23)          52.25 (3.32)       0.79 (3.90)                                                                    0.59 (4.00)      
  Satisfaction with Social Roles and Activities                                                                                                                                                             
   SCT                                            51.05 (10.14)     53.02 (11.50)         49.08 (10.96)      2.76 (8.89)                              0.518                                 −1.53 (9.79)    0.021^[\*](#tf12){ref-type="table-fn"}^
   TAU                                            52.99 (10.79)     55.06 (10.84)         45.52 (11.10)      1.43 (8.67)                                                                    −7.38 (11.79)    
  Physical Function                                                                                                                                                                                         
   SCT                                            27.84 (7.46)      27.00 (6.64)          34.63 (6.38)       −0.74 (3.22)                             0.416                                 6.54 (6.77)     0.232
   TAU                                            25.58 (6.78)      24.60 (6.63)          34.20 (6.91)       −0.04 (4.03)                                                                   8.73 (8.99)      
  Depression                                                                                                                                                                                                
   SCT                                            49.25 (8.75)      45.38 (7.18)          46.20 (7.57)       −3.08 (7.12)                             0.313                                 −3.23 (7.17)    0.819
   TAU                                            47.11 (7.89)      46.54 (8.22)          44.19 (6.37)       −0.99 (10.29)                                                                  −2.85 (6.99)     

*t* Test on delta change.

*t*-test, *p* \< 0.05.

SCT, self-care toolkit; SD, standard deviation; TAU, treatment as usual.

### Baseline (T1) to follow-up (T4) time interactions {#s019}

Several significant between-group mean differences were observed when examining the time interaction between T1 and T4 ([Table 5](#T5){ref-type="table"}). The mean change in Pain Interference was significant (*p* = 0.005) with a larger increase in Pain Interference in the TAU group (mean difference: 9.93 \[TAU\] vs. 2.89 \[SCT\]). While Fatigue was significantly higher among SCT participants at baseline, both groups were equivalent at the 2-week follow-up. The mean change in Fatigue from T1 to T4 was also significantly greater in the TAU group (4.13 \[TAU\] vs. 0.02 \[SCT\], *p* = 0.023). Satisfaction with Social Roles and Activities significantly decreased in the TAU group and plateaued in the SCT group (*p* = 0.021). There were nonsignificant differences in Anxiety (*p* = 0.099), Pain Intensity (*p* = 0.095), or Sleep Disturbance (*p* = 0.351) over this time period.

### Group by time interactions {#s020}

There were significant group-by-time interaction effects for Pain Interference (*p* = 0.0152), Fatigue (*p* = 0.0288), and Social Roles and Activities (*p* = 0.0130) in RM-ANOVA. There were no significant interaction effects in PROMIS subscales for Anxiety, Pain Intensity, or Sleep Disturbance. The results of the QOL Survey (QLQ-C30) showed no difference between the two study groups (data not shown).

### Preoperative (T2) to postoperative (T3) {#s021}

There was a significant difference in mean change in DVPRS scores from T2 to T3, with the SCT group having a lower increase in postoperative pain (mean difference: 1.2 \[SCT\] vs. 3.14 \[TAU\], *p* = 0.008). VAS nausea scores increased less for the SCT group. VAS anxiety decreased for both groups, more so in the SCT group ([Table 6](#T6){ref-type="table"}).

###### 

[Mean Perioperative Change in Defense and Veterans Pain Rating Scale and Visual Analog Scale Variable Scores]{.smallcaps}

                   *Group*          *Mean change (T3--T2)*   *SD*    *SE mean*   p
  ---------------- ---------------- ------------------------ ------- ----------- -----------------------------------------
  DVRPS Pain       SCT (*n* = 35)   1.200                    2.774   0.469       0.008^[\*](#tf14){ref-type="table-fn"}^
  TAU (*n* = 35)   3.143            3.126                    0.528               
  VAS Anxiety      SCT (*n* = 33)   −2.364                   3.151   0.548       0.269
  TAU (*n* = 35)   −1.486           3.346                    0.566               
  VAS Nausea       SCT (*n* = 35)   0.857                    3.060   0.517       0.141
  TAU (*n* = 35)   2.029            3.510                    0.593               

Wilcoxon *p* \< 0.05.

DVRPS, Defense and Veterans Pain Rating Scale; SD, standard deviation; SE, standard error; VAS, Visual Analog Scale.

While these between-group differences were not statistically significant for either nausea or anxiety (*p* = 0.141 and *p* = 0.269, respectively), the overall trend suggests a decrease in both variables from pre- to postoperative in the SCT group ([Fig. 2](#f2){ref-type="fig"}).

![Mean differences in pain, nausea, and anxiety from preoperative (T2) to postoperative (T3). Data displayed as mean ± SEM. Wilcoxon *p*-value = 0.008. DVRPS, Defense and Veterans Pain Rating Scale; SCT, self-care toolkit; SEM, standard error of the mean; TAU, treatment as usual; VAS, Visual Analog Scale.](fig-2){#f2}

Laboratory results {#s022}
------------------

While both CRP and ESR increased from T2 to T4 in the TAU group, the SCT group\'s values did not show a similarly spiked increase ([Fig. 3](#f3){ref-type="fig"}); however, only the ESR group by time interaction was significant at T4 (*p* = 0.0197). ESR subgroup analysis showed statistically significant between-group differences from T1 to T4 favoring the SCT group in the rate of increase in ESR among mastectomy, but not lumpectomy, patients (*p* = 0.023) ([Fig. 4](#f4){ref-type="fig"}).

![Mean ESR and CRP levels over time. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; SCT, self-care toolkit; TAU, treatment as usual.](fig-3){#f3}

![Mean difference in ESR T4 versus T1 by surgical procedure. Data displayed as mean ± SEM. Wilcoxon *p*-values by surgery type: mastectomy, *p* = 0.023; lumpectomy, *p* = 0.8339; Wilcoxon *p*-values by randomization arm: SCT, *p* = 0.456; TAU, *p* = 0.008. ESR, erythrocyte sedimentation rate; SCT, self-care toolkit; TAU, treatment as usual.](fig-4){#f4}

Discussion {#s023}
==========

The primary hypothesis was that anxiety would decrease in the SCT group during the main intervention period from baseline to preoperative. While anxiety decreased a mean 5.08 T-scale points in the SCT and 1.7 in TAU groups, these between-group differences did not reach statistical significance. Nonetheless, this decrease in anxiety in the SCT group represents a clinically meaningful change, since a MID range of 3.0--4.5 in the PROMIS-Cancer Anxiety subscale has been found in persons with advanced cancers.^[@B28]^ While the average decrease in anxiety was even greater for the SCT group from baseline to follow-up (mean, 8.96), anxiety also decreased substantially during this time period for the TAU group as well (mean, 5.69), possibly explained by a lessening of preoperative anxiety once surgery had occurred. Both the SCT and TAU groups had substantially elevated anxiety at baseline (mean, 59.9 and 55.2, respectively), well above the 49.6 reference range for anxiety in newly diagnosed breast cancer patients.^[@B29]^ This heightened anxiety at baseline is likely due to the short interval between when participants learned of their treatment plan and the consenting research appointment.

Another unexpected finding is that the SCT group had significantly higher fatigue compared with the TAU group at baseline. The authors did not find any significant baseline differences between groups on demographic variables (e.g., type of surgery and cancer stage), nor did they collect data that might account for these baseline differences (e.g., pre-existing psychological conditions, prognosis, genetic risk factors, and postoperative treatment plan). Consequently, the authors are unable to definitively attribute the cause of these baseline between-group differences. One possible explanation is that since the IRB required an opt-in section of the consent to participate in qualitative interviews only for the SCT group, there may have been concern at baseline among SCT participants about the burden of additional research-related requirements.

The significant mean increase in Pain Interference from baseline to follow-up was 9.93 T-scale points in the TAU and 2.89 in the SCT group, reflecting Pain Interference in the TAU group that exceeded the MID range of 4.0--6.0.^[@B28]^ This statistically and clinically significant difference between groups suggests that the SCT group did not experience Pain Interference to the same extent as the TAU did. Fatigue was higher at baseline and stayed relatively constant at T2 and T4 in the SCT group, whereas it worsened 4.13 T-scale points in the TAU group within the clinically relevant MID range of 3.0--5.0.^[@B28]^ Although the authors cannot definitely attribute the cause, the pre- and postoperative tracks contained posthypnotic suggestions for comfort, ease, vitality, and vigor increasing each day as healing occurs.

Inflammatory conditions such as cancer, surgery, and tissue infarction commonly lead to changes in serum levels of acute-phase reactants (APRs) such as ESR and CRP.^[@B30]^ Recent studies show linkages between inflammation and psychological stress and that relaxation techniques can reduce physiologic and genetic markers of inflammation.^[@B25],[@B31]^ In this study, the authors used ESR and CRP to investigate whether the SCT influenced the degree and duration of postoperative inflammation. These results showed a statistically significant between-group difference in the 2-week postsurgical ESR and a simultaneous, nonsignificant decrease in CRP ([Fig. 3](#f3){ref-type="fig"}). Since both ESR and CRP showed similar trends in the postsurgical state, the SCT intervention may have had a direct or indirect effect on APR and proinflammatory cytokine secretion. The blunted rise in postoperative ESR in the SCT group may imply an improvement in wound healing associated with decreased proinflammatory cytokine levels.^[@B35],[@B36]^ An unanticipated finding was that mastectomy patients in the SCT group had significantly lower postsurgical ESR compared with TAU mastectomy patients. It would be expected that mastectomy patients would have a greater increase in APRs since mastectomy is a more invasive surgery than lumpectomy.

Challenges and limitations {#s024}
--------------------------

Several challenges were encountered during the course of this study. Following lengthy administrative processes for military IRB approval, the authors added a second site at CRDAMC to increase enrollment; however, many of their breast cancer patients were referred to other facilities. Another challenge was initiating the intervention at time of diagnosis. Although this seemed an ideal time to introduce a potentially helpful intervention for emotional distress, it was not a priority for many, explaining the high percentage of screened patients who declined to participate. Finally, during this 3-year study, the MP3 player intervention used was outpaced by technologic advances in mobile applications.

Conclusion {#s025}
==========

The mind--body skills used in this study, specifically meditation, guided imagery and self-hypnosis, have been shown to relieve distress and pain related to cancer and surgery. The authors created a customized SCT with guided meditations to teach individuals how to recognize and self-manage physical and emotional reactions to stressful events from cancer diagnosis and surgical treatment. They found significant differences in Pain Interference, Fatigue, and Satisfaction with Social Roles in the SCT group compared with TAU from baseline to follow-up. In the immediate perioperative period, the SCT group had a smaller increase in postoperative pain as measured by the DVPRS compared with the TAU group. There was also a significantly greater difference in ESR, but not CRP, favoring the SCT group at follow-up. These results suggest individuals may derive benefits from these practices without accompanying harm. These techniques may provide a healthy method of coping and increased resilience throughout cancer treatment.
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